Article
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
American journal of hematology - 1 Mar 2024
Moukalled Nour, Labopin Myriam, Versluis Jurjen, Socié Gérard, Blaise Didier, Salmenniemi Urpu, Rambaldi Alessandro, Gedde-Dahl Tobias, Tholouli Eleni, Kröger Nicolaus, Bourhis Jean-Henri, Von Dem Borne Peter, Daguindau Etienne, Forcade Edouard, Nagler Arnon, Esteve Jordi, Ciceri Fabio, Bazarbachi Ali, Mohty Mohamad
Abstract excerpt
In the 2022 European LeukemiaNet classification, patients with nucleophosmin 1 (NPM1)-mutated acute myeloid leukemia (AML) were classified in the adverse-risk category in the presence of high-risk cytogenetics (CG). Nonetheless, the impact of various CG aberrations on posttransplant outcomes remains to be unraveled. This registry study analyzed adult patients with NPM1-mutated de novo AML who underwent their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
